Isabelle Aubert
Affiliations: | Laboratory Medicine and Pathobiology | University of Toronto, Toronto, ON, Canada |
Google:
"Isabelle Aubert"Mean distance: 13.9 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorSerge Gauthier | grad student | University of Toronto | |
Remi Quirion | grad student | McGill | |
Fred H. (Rusty) Gage | post-doc | Salk Institute |
Children
Sign in to add traineeDanielle Weber-Adrian | grad student | 2012- | University of Toronto |
Zeinab Noroozian | grad student | 2014- | University of Toronto |
Jessica F. Jordao | grad student | 2013 | University of Toronto |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kofoed RH, Aubert I. (2024) Focused ultrasound gene delivery for the treatment of neurological disorders. Trends in Molecular Medicine |
Grewal S, Gonçalves de Andrade E, Kofoed RH, et al. (2023) Using focused ultrasound to modulate microglial structure and function. Frontiers in Cellular Neuroscience. 17: 1290628 |
Kofoed RH, Simpson EM, Hynynen K, et al. (2023) Sonoselective delivery using ultrasound and microbubbles combined with intravenous rAAV9 CLDN5-GFP does not increase endothelial gene expression. Gene Therapy |
Gouveia FV, Lea-Banks H, Aubert I, et al. (2023) Anesthetic-loaded nanodroplets with focused ultrasound reduces agitation in Alzheimer's mice. Annals of Clinical and Translational Neurology |
Meng Y, Goubran M, Rabin JS, et al. (2023) Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound. Brain : a Journal of Neurology |
Kofoed RH, Noseworthy K, Wu K, et al. (2022) The engineered AAV2-HBKO promotes non-invasive gene delivery to large brain regions beyond ultrasound targeted sites. Molecular Therapy. Methods & Clinical Development. 27: 167-184 |
Kofoed RH, Dibia CL, Noseworthy K, et al. (2022) Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas. Journal of Controlled Release : Official Journal of the Controlled Release Society. 351: 667-680 |
Xhima K, Markham-Coultes K, Kofoed RH, et al. (2021) Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies. Brain : a Journal of Neurology |
Kofoed RH, Heinen S, Silburt J, et al. (2021) Transgene distribution and immune response after ultrasound delivery of rAAV9 and PHP.B to the brain in a mouse model of amyloidosis. Molecular Therapy. Methods & Clinical Development. 23: 390-405 |
Xhima K, McMahon D, Ntiri E, et al. (2021) Intravenous and Non-invasive Drug Delivery to the Mouse Basal ForebrainUsing MRI-guided Focused Ultrasound. Bio-Protocol. 11: e4056 |